21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
#24002Sequential SPRM/ progestin treatment
#24003Sequential SPRM/progestin treatment
#24004Combination therapy for the treatment of cancer
#24005Gnrh agonist combination drugs
#24006Methods and compositions for improving photodynamic therapy through administration of lipids
#24007β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
#24008Modafinil combination therapy for improving sleep quality
#24009Treatment method against side-effects of chemotherapy
#24010Compositions of bacteria and alpha-lactalbumin and uses thereof
#24011Pharmaceutical compositions containing exendins
#24012Preparation method of the conjugated linoleic acid diglycerides
#24013Hippophae rhamnoides compositions for cancer therapy
#24014Treatments for immune systems disorders
#24015Bioavailability enhancing activity of Carum carvi extracts and fractions thereof
#24016Low-dose potassium supplementation for the prevention and treatment of hypertension
#24017Chromium/biotin treatment of dyslipidemia and diet-induced post prandial hyperglycemia
#24018Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
#24019Multi-vitamin and mineral nutritional supplements
#24020Microparticles for cell delivery
#24021Appetite suppressant
#24022Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
#24023Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
#24024Diabetic nephropathy therapies
#24025Treatment method
#24026Methods and compositions for modulating angiogenesis
#24027Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
#24028Poly(potassium and sodium styrene sulfonate), its manufacture and its uses
#24029Menopause homeopathic formulations
#24030Feminine homeopathic formulations
#24031Compositions containing internally activated antioxidant
#24032Pharmaceutical composition and nasal rinsing device therefor
#24033Antibodies that immunospecifically bind to TRAIL receptors
#24034Antibodies that immunospecifically bind to TRAIL receptors
#24035Quinolinone derivatives
#24036Treatment of cancer using benzoic acid derivatives
#24037Potentiation of therapeutic effects of fatty acids
#24038Alphahydroxyacids with ultra-low metal concentration
#24039Platinum carboxylate anticancer compounds
#24040Method and compositions for treatment of chronic neuropathic pain
#24041Methods for modulating tumor growth and metastasis
#24042Method of treatment for high neurotransmitter pattern
#24043Cancer therapy
#24044Compositions comprising (S)-amlodipine malate and an angiotensin receptor blocker and methods of their use
#24045Quinuclidine derivatives and medicinal compositions containing the same
#24046Therapeutic combinations of atypical antipsychotics with corticotropin releasing factor antagonists
#24047Treatment of peripheral neuropathy
#24048Methods and compositions for the treatment of psychiatric conditions
#24049Use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune disorders
#24050Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
#24051Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
#24052Treatment of age-related lung abnormalities using estrogen and/or retinoids
#24053Use of vitamin Ds or vitamin D analogs to treat cardiovascular disease
#24054Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
#24055Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV
#24056Combination therapy for glaucoma treatment
#24057Oligodeoxynucleotide and its use to induce an immune response
#24058Combined therapeutical treatment of hyperproliferative diseases
#24059Treatment of periodontal disease
#24060Breast health preparations
#24061Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors
#240624-Biarylyl-1-phenylazetidin-2-ones
#24063Polypeptoid pulmonary surfactants
#24064Mast cell-derived renin
#24065Compositions and methods for treatment of rosacea
#24066Methods and reagents for diagnosis and treatment of diabetes
#24067Compositions containing avocado leaf extract for lowering cholesterol levels
#24068Esterified fatty acid composition
#24069Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
#24070Pharmacological composition based on biologically active substances obtained from tribulus terrestris l
#24071Plants extracts and the use thereof
#24072Compositions for elastogenesis and connective tissue treatment
#24073Anti-angiogenic compositions and methods of use
#24074Composition and method for healing tissues
#24075Composition containing oat straw and willow herb extract
#24076Bone cement compositions having fiber-reinforcement and/or increased flowability
#24077Compositions of botanical extracts for cancer therapy
#24078Use of agonists and antagonists of IL-23 in the treatment of viral infection
#24079Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
#24080Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
#24081Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
#24082Phage-associated lytic enzymes for treatment of and related conditions
#24083Nutritional composition for treating an immune condition
#24084Natural vaginal yeast infection control
#24085Lactic acid bacteria and their use in the treatment of cancer
#24086Nutrient Medium for maintaining neural cells in injured nervous system
#24087Oncolytic virus therapy
#24088Immuno-modulating effects of chemokines in DNA vaccination
#24089Aerosol formulations containing P134a and particulate medicament
#24090High storage stability inhalable compositions
#24091Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
#24092Formoterol and ciclesonide aerosol formulations
#24093Aromatherapy delivery system
#24094C-nitroso compounds and use thereof
#240951-Aminocyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease
#24096Methods of treating gastrointestinal tract disorders using sodium channel modulators
#24097Pharmaceutical compositions and method of using levodopa and carbidopa
#24098Combination therapies using leptomycin B
#24099Methods and compositions for treating diseases associated with excesses in ACE
#24100Indole-3-acetic acid derivatives
#24101β crystalline form of perindopril tert-butylamine salt
#24102Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer
#24103Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
#24104Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
#24105Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
#24106Compounds for the sustained reduction of body weight
#24107Substituted piperidine compounds and methods of their use
#24108Methods of using SNS-595
#24109Composition and method for controlling alcohol-induced facial flushing in susceptible humans
#24110Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
#24111Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
#24112Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents
#24113Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
#24114Compositions and methods for treatment of mitochondrial diseases
#24115Methods of using thalidomide in combination with irinotecan
#24116Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
#24117Complex immuno-gene medical composition for inhibiting tumor cells
#24118Multi-action anthelmintic formulations
#24119Novel effectors of dipeptidyl peptidase IV
#24120Method for pharmacoperones correction of GnRHR mutant protein misfolding
#24121Pharmaceutical composition for thrombin peptide derivatives
#24122Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
#24123Composition comprising zinc-containing layered material with a high relative zinc lability
#24124Organ arrest, protection, preservation and recovery
#24125Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent
#24126Methods and compositions for inhibiting monoamine oxidase and catechol-o-methyltransferase
#24127Pregnane glycoside compositions and extract products and uses thereof
#24128Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
#24129Unit dose of material in system and method
#24130Storage stable tablets of fosinopril sodium
#24131Vesicle-encapsulated corticosteroids for the treatment of cancer
#24132Method of administering liposomal encapsulated taxane
#24133Alfalfa sprout powder based supplement
#24134Single tank process for preparing tannate liquid and semi-solid dosage forms
#24135Composition and method for minimizing residual fecal matter in the perianal area
#24136Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith
#24137Method and composition for altering a B cell mediated pathology
#24138Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases
#24139Multipeptide regimen for the treatment of autistic spectrum, behavioral, emotional and visceral inflammation/autoimmune disorders
#24140Tumor and infectious disease therapeutic compositions
#24141Bed sore medicine cream
#24142LUPEOL ANTI-TUMOR AGENT AND USES THEREOF
#24143Method for selectively inhibiting ghrelin action
#24144Method of treatment of lung cancer
#24145Treatment of hematologic tumors and cancers with beta-lapachone, a broad spectrum anti-cancer agent
#24146Method of augmenting the antitumor activity of anticancer agents
#24147Therapeutic agent for hepatic disease
#24148Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite
#24149Methods of treating an inflammatory-related disease
#24150Concomitant drugs
#24151COMPOUNDS USEFUL IN PREPARING CAMPTOTHECIN DERIVATIVES
#24152Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
#24153Compounds capable of binding to proteins constituting or associated with cytoskeletal elements, and their applications for the manufacture of medicaments
#24154Treatment of sepsis
#24155Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
#24156Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
#24157Antiparasitic composition
#24158Peptidomimetic protease inhibitors
#24159Method of increasing bone toughness and stiffness and reducing fractures
#24160Method of treating corneal transplant rejection in high risk keratoplasty patients
#24161Human secreted proteins
#24162Neuroprotective synergy of erythropoietin and insulin-like growth factors
#24163Compositions and methods for treatment of Psoriasis
#24164Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
#24165Antioxidant combination composition and use thereof
#24166Supplement foods and pharmaceuticals
#24167Herbal composition PHY906 and its use in chemotherapy
#24168Method and composition for enhancing sexual desire
#24169Micronutrient supplement combination for acne treatment and prevention
#24170Composition and method for nutritional supplement for drug abuse treatment and rehabilitation
#24171Treatment system including carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and deterium reduced aqueous fluid and method using the same
#24172Hangover relief composition
#24173Pharmaceutical composition and method for the transdermal delivery of magnesium
#24174Seaweed extract composition for treatment of inflammation
#24175Compositions of botanical extracts for treating malignancy-associated changes
#24176Prevention and treatment of amyloidogenic disease
#24177Enhanced production of blood clotting factors and fibrin fabric
#24178Chlorella containing nutritional supplement having improved digestability
#24179Antiviral oligonucleotides targeting viral families
#24180Combination therapies with L-FMAU for the treatment of hepatitis B virus infection
#24181Defecation deodorant
#24182Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
#24183Method and composition for treating oral bacteria and inflammation
#24184Use of a VEGF antagonist in combination with radiation therapy
#24185Biological response modifier for the treatment of cancer
#24186Antibodies to vascular endothelial growth factor 2 (VEGF-2)
#24187Method of treatment of colon cancer
#24188Method of treatment of pancreatic cancer
#24189Synergistic anti-inflammatory pharmaceutical compositions and methods of use
#24190Compositions of non-steroidal anti-inflammatory drugs and decongestants or anti-histamines
#24191(2-Carboxamido)(3-amino)thiophene compounds
#24192Spot-on formulations for combating parasites
#24193Method of preventing abuse of opioid dosage forms
#24194Method of treating or preventing hepatitis B virus
#24195Treatment of behavioral disorders
#24196Combinations of drugs for the treatment of neoplastic disorders
#24197Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
#24198Use of selective chloride channel modulators to treat alcohol and/or stimulant substance abuse
#24199Methods of decreasing intestinal motility
#24200Use of targeted oxidative therapeutic formulation in treatment of viral diseases
#24201Treatment of tumours
#24202Methods and reagents for the treatment of immunoinflammatory disorders
#24203Aldosterone antagonist compositions for release during aldosterone acrophase
#24204Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease
#24205Nitroxyl progenitors in the treatment of heart failure
#24206Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
#24207Method of treating cancers
#24208Medicinal composition for treating arteriosclerosis
#24209Neuromuscular blocking agents and antagonists thereof
#24210Therapeutic fusion protein transgenes
#24211Method for reducing the risk of cancer
#24212Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
#24213Methods for treating Parkinson's disease
#24214Pharmaceutical preparations and medicines capable of generating, and/or containing, thrombin
#24215Pharmaceutical preparations and medicine capable of generating and/or containing thrombin
#24216Method for reducing pain
#24217Medium chain peroxycarboxylic acid compositions
#24218Hangover remedy and alcohol abatement composition
#24219Antimicrobial composition for pre-harvest and post-harvest treatment of plants and animals
#24220Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
#24221Device and method for treatment of wounds with nitric oxide
#24222Medical composition
#24223Compositions comprising vitamin E and saw palmetto
#24224Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
#24225Use of enhanced water to improve blood sugar management
#24226Promoting cell regeneration and/or cell differentiation with non-metabolizable sugar and a polymeric absorbent
#24227Once daily dosage forms of trospium
#24228Galantamine formulations
#24229Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
#24230Liposomal composition comprising L-theanine
#24231Opioid-receptor antagonists in transdermal systems having buprenorphine
#24232Prevention and treatment of amyloidogenic disease
#24233Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation
#24234Induction of antigen specific immunologic tolerance
#24235Method of treating hemolytic disease
#24236Prevention and treatment of amyloidogenic disease
#24237Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair
#24238Anti-photoaging cosmeceutical composition
#24239Medical implants and fibrosis-inducing agents
#24240Abuse-resistant pharmaceutical dosage form
#24241Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
#24242Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
#24243Hyperlipemia therapeutic agent
#24244Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
#24245Compositions comprising (S)-amlodipine and an angiotensin receptor blocker and methods of their use
#24246Hydroxamates as therapeutic agents
#24247Synergistic l-methadone compositions and methods of use thereof
#24248Meloxicam for the treatment of respiratory diseases in pigs
#24249Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
#24250Medicinal composition for lowering blood lipid level
#24251Methods and reagents for the treatment of inflammatory disorders
#24252Methods and reagents for the treatment of inflammatory disorders
#24253Topical composition
#24254Pharmaceutical applications of hyaluronic acid preparations
#24255Antineoplastic combinations
#24256Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
#24257Combination of a Cox-2 inhibitor and a DNA topoisomerase I inhibitor for treatment of neoplasia
#24258Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
#24259C-nitroso compounds and use thereof
#24260Methods for accelerating bone, cartilage, and connective tissue growth
#24261Peptide with osteogenic activity
#24262Pharmaceutical compositions based on anticholinergics and pegsunercept
#24263Methods and compositions for modulating adipocyte function
#24264Antitumor agent
#24265Antitumor agent
#24266Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
#24267Methods and systems for enabling and stabilizing tooth movement
#24268Profiles of lipid proteins and inhibiting HMG-CoA reductase
#24269Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of vardenafil for the treatment of female sexual dysfunction
#24270Tea for treating dermatitis comprising herbal extracts
#24271Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
#24272Gastroprotected formulations containing alph-amylase inhibitors
#24273Novel formulations for the administration of fluoxetine
#24274Multilayer tablet
#24275Stabilized feverfew formulations
#24276Medical implants and fibrosis-inducing agents
#24277Treatment with anti-VEGF antibodies
#24278Detection of CD20 in therapy of autoimmune diseases
#24279Anti-IGF-I receptor antibody
#24280Antioxidant combination composition and use thereof
#24281Method for treatment of tendinosis using platelet rich plasma
#24282Novel microorganism strain GM-020 of Lactobacillus rhamnosus and its use for treating obesity
#24283Compositions containing probiotics and polysaccharides and methods of use
#24284Oncolytic adenoviral vectors encoding GM-CSF
#24285Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins
#24286Cosmetic composition capable of fighting against skin aging
#24287Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
#24288Treatment methods
#24289Abuse-proofed dosage form
#24290Compositions, methods, apparatuses, and systems for singlet oxygen delivery
#24291Still camera with audio decoding and coding, a printable audio format, and method
#24292Phosphorous-containing compounds with polymeric chains, and methods of making and using the same
#24293Antiseptic disinfectant, and cosmetics and toiletries, medicine or food containing the same
#24294N-acetylcysteine compositions and methods for the treatment and prevention of endothelial dysfunction
#24295Microbiological control in poultry processing
#24296Medicinal composition for mitigating blood lipid or lowering blood homocysteine
#24297Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
#24298Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
#24299Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
#24300Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist